Metagenomi Investor Relations Material
Latest events
Study Update
Metagenomi
Q1 2025
13 May, 2025
Q4 2024
17 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Metagenomi Inc
Access all reports
Metagenomi Inc. is a biotechnology firm specializing in genetic medicines through its advanced metagenomics-derived genome editing technologies. The company leverages a proprietary toolbox that includes a variety of programmable nucleases, base editors, and RNA and DNA-mediated integration systems. These tools are designed to create precise and curative genetic therapies. Metagenomi focuses on developing these therapies to treat a range of serious diseases by harnessing naturally evolved microbial systems to enhance genome editing capabilities. The company is headquartered in Emeryville, California, and its shares are listed on the NASDAQ.
Key slides for Metagenomi Inc
Corporate Presentation
Metagenomi Inc
Corporate Presentation
Metagenomi Inc
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
MGX
Country
🇺🇸 United States